Oculis to Attend Investor Conferences Scheduled for September

Written by Emily J. Thompson, Senior Investment Analyst

Source: Globenewswire

Updated: Aug 27 2025

0mins

Source: Globenewswire

Upcoming Investor Conferences: Oculis Holding AG will participate in several investor conferences throughout September, including the Wells Fargo Healthcare Conference and H.C. Wainwright 27th Annual Global Investment Conference.
Key Management Participation: CEO Riad Sherif, M.D., and CFO Sylvia Cheung will represent the company at these events, with scheduled presentations and fireside chats.
Company Updates and Webcasts: Oculis will provide updates on its clinical pipeline during the conferences, and webcast links for these presentations will be available on their website.
Focus on Innovative Treatments: Oculis is dedicated to developing solutions for ophthalmic and neuro-ophthalmic diseases, with a late-stage clinical pipeline that includes three core product candidates targeting significant unmet medical needs.

About the author

Emily J. Thompson

Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.

GET FREE REAL TIME NOTIFICATIONS

Stock Monitor for NVDA?

Get Started Free

FREE STOCK RECOMMENDATIONS DAILY

Stock Bullish Tomorrow

Get Started Free

70% BACKTESTED ACCURACY!

Should I Buy NVDA?

Get Started Free